Sales decline 6.68% to Rs 524.63 crore
Net profit of Epigral rose 0.72% to Rs 77.28 crore in the quarter ended March 2024 as against Rs 76.73 crore during the previous quarter ended March 2023. Sales declined 6.68% to Rs 524.63 crore in the quarter ended March 2024 as against Rs 562.18 crore during the previous quarter ended March 2023.For the full year,net profit declined 44.57% to Rs 195.82 crore in the year ended March 2024 as against Rs 353.29 crore during the previous year ended March 2023. Sales declined 11.84% to Rs 1929.19 crore in the year ended March 2024 as against Rs 2188.40 crore during the previous year ended March 2023.
ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales524.63562.18 -7 1929.192188.40 -12 OPM %29.6227.51 -24.9431.48 - PBDT143.84140.20 3 414.26631.41 -34 PBT113.46110.07 3 290.70522.46 -44 NP77.2876.73 1 195.82353.29 -45
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
